{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T14:43:13Z","timestamp":1793889793343,"version":"4.8.0"},"reference-count":39,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["Grant from the Italian Ministry of Health to IRCCS"],"award-info":[{"award-number":["Grant from the Italian Ministry of Health to IRCCS"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Ther Adv Neurol Disord"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Lasmiditan, an oral 5-HT\n                      <jats:sub>1F<\/jats:sub>\n                      receptor agonist, has been recently approved for acute migraine treatment. While its efficacy was confirmed in randomized clinical trials, scarce data is available regarding effectiveness and tolerability in the real-world setting.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>To evaluate lasmiditan effectiveness and tolerability in the real-world setting in 16 Italian headache centers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>LasmiDitan as Acute migRaine Treatment (DART) study is a prospective, multicentric, observational study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We enrolled 58 participants with migraine (84.5% females, age 49.0 (45.2\u201352.9) years, 24.1% with chronic migraine) reporting 9.4 (7.4\u201311.3) monthly migraine days. Participants were instructed to treat their migraine attacks with oral lasmiditan 50 or 100\u2009mg. Using an ad hoc electronic diary, participants prospectively collected migraine attack features at baseline and every 30\u2009min after lasmiditan administration, up to 2\u2009h post-dose. The primary outcome was 2-h pain freedom for the first-treated attack after lasmiditan intake. We also collected the occurrence of treatment-emergent adverse events (AE) after administration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Overall, participants treated 100 attacks, of which 58 first-treated attacks. Regarding first-treated attacks, 44.8% of subjects rated migraine intensity as severe at lasmiditan intake. Pain freedom 2-h post-dosing was reported in 32.8% (19\/58) of individuals and was associated with baseline pain intensity, being higher in subjects treating a mild\/moderate attack (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.044). Conversely, it was not influenced by timing of intake (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.375), dosage (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.727), or previous triptan failure (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.351). Regarding all-treated attacks, pain freedom 2-h post-dosing was 37.0% (37\/100). At least one AE was reported by 53.4% of participants (31\/58), predominantly asthenia, dizziness, somnolence, anxiety or agitation, and paresthesia. Tolerability was rated as good-to-excellent by 51.8% of subjects.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Our study supports clinical effectiveness of oral lasmiditan 50 and 100\u2009mg for the treatment of acute migraine attacks. Lasmiditan effectiveness was not associated with the previous triptan failure and may therefore represent a valuable therapeutic option in subjects who did not benefit from, or have contraindications to, triptans.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trail registration:<\/jats:title>\n                    <jats:p>\n                      The study was preregistered on clinicaltrial.gov, NCT05903040 (\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT05903040?cond=migraine&amp;intr=lasmiditan&amp;rank=5\">https:\/\/clinicaltrials.gov\/study\/NCT05903040?cond=migraine&amp;intr=lasmiditan&amp;rank=5<\/jats:ext-link>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/17562864251381886","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T07:02:37Z","timestamp":1766386957000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":5,"title":["Effectiveness and tolerability of lasmiditan in the acute treatment of migraine: a real-world, prospective, multicentric study (DART study)"],"prefix":"10.1177","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0117-7126","authenticated-orcid":false,"given":"Gloria","family":"Vaghi","sequence":"first","affiliation":[{"name":"Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy"},{"name":"Headache Science and Neurorehabilitation Unit, IRCCS Mondino Foundation, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi Francesco","family":"Iannone","sequence":"additional","affiliation":[{"name":"Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy"},{"name":"Digital and Predictive Medicine, Pharmacology, Clinical Metabolic Toxicology-Headache Center and Drug Abuse, Laboratory of Clinical Pharmacology and Pharmacogenomics, AOU Policlinico, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Corrado","sequence":"additional","affiliation":[{"name":"Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy"},{"name":"Headache Science and Neurorehabilitation Unit, IRCCS Mondino Foundation, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8059-6427","authenticated-orcid":false,"given":"Federico","family":"De Santis","sequence":"additional","affiliation":[{"name":"Department of Biotechnological and Applied Clinical Sciences, University of L\u2019Aquila, L\u2019Aquila, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6016-3141","authenticated-orcid":false,"given":"Marina","family":"Romozzi","sequence":"additional","affiliation":[{"name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Universit\u00e0 Cattolica del Sacro Cuore, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Sebastianelli","sequence":"additional","affiliation":[{"name":"Department of Medico-Surgical Sciences and Biotechnologies, Polo Pontino, Sapienza University of Rome, Latina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Dalla Volta","sequence":"additional","affiliation":[{"name":"Headache Center of Neurological Unit of Istituto Clinico Citt\u00e0 di Brescia, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5161-5545","authenticated-orcid":false,"given":"Marco","family":"Bolchini","sequence":"additional","affiliation":[{"name":"Headache Center of Neurological Unit of Istituto Clinico Citt\u00e0 di Brescia, Brescia, Italy"},{"name":"Headache Center of Neurological Unit of Istituto Clinico Citt\u00e0 di Brescia, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Burgalassi","sequence":"additional","affiliation":[{"name":"Headache Center and Clinical Pharmacology, AOU Careggi, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"De Cesaris","sequence":"additional","affiliation":[{"name":"Headache Center and Clinical Pharmacology, AOU Careggi, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5113-2017","authenticated-orcid":false,"given":"Maria","family":"Albanese","sequence":"additional","affiliation":[{"name":"Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Mercuri Biagio","sequence":"additional","affiliation":[{"name":"Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Ornello","sequence":"additional","affiliation":[{"name":"Department of Biotechnological and Applied Clinical Sciences, University of L\u2019Aquila, L\u2019Aquila, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0651-1939","authenticated-orcid":false,"given":"Simona","family":"Sacco","sequence":"additional","affiliation":[{"name":"Department of Biotechnological and Applied Clinical Sciences, University of L\u2019Aquila, L\u2019Aquila, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0790-4240","authenticated-orcid":false,"given":"Francesca","family":"Pistoia","sequence":"additional","affiliation":[{"name":"Department of Biotechnological and Applied Clinical Sciences, University of L\u2019Aquila, L\u2019Aquila, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"Saporito","sequence":"additional","affiliation":[{"name":"Department of Biotechnological and Applied Clinical Sciences, University of L\u2019Aquila, L\u2019Aquila, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Casillo","sequence":"additional","affiliation":[{"name":"Department of Medico-Surgical Sciences and Biotechnologies, Polo Pontino, Sapienza University of Rome, Latina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2878-560X","authenticated-orcid":false,"given":"Gianluca","family":"Avino","sequence":"additional","affiliation":[{"name":"Neurology Unit, Ospedale Santo Stefano, USL Toscana Centro, Prato, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Granato","sequence":"additional","affiliation":[{"name":"Headache Centre, Clinical Unit of Neurology, School of Neurology, Department of Medicine, Surgery and Health Sciences, University Hospital and Health Services of Trieste, ASUGI, University of Trieste, Trieste, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Russo","sequence":"additional","affiliation":[{"name":"Headache Centre, Department of Advanced Medical and Surgical Sciences, University of Campania \u201cLuigi Vanvitelli,\u201d Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Silvestro","sequence":"additional","affiliation":[{"name":"Headache Centre, Department of Advanced Medical and Surgical Sciences, University of Campania \u201cLuigi Vanvitelli,\u201d Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catello","family":"Vollono","sequence":"additional","affiliation":[{"name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Universit\u00e0 Cattolica del Sacro Cuore, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6058-3912","authenticated-orcid":false,"given":"Michele","family":"Trimboli","sequence":"additional","affiliation":[{"name":"Department of Neurology, AOU Renato Dulbecco, Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1015-7365","authenticated-orcid":false,"given":"Alberto","family":"Doretti","sequence":"additional","affiliation":[{"name":"Department of Neuroscience\u2014Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariarosaria","family":"Valente","sequence":"additional","affiliation":[{"name":"DMED, University of Udine and Clinical Neurology, Udine University Hospital, Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Cevoli","sequence":"additional","affiliation":[{"name":"IRCCS Istituto di Scienze Neurologiche di Bologna, Programma Cefalee e Algie Facciali, Bologna, Italia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Mampreso","sequence":"additional","affiliation":[{"name":"Headache Centre, Neurology\u2014Euganea, Health Unit, Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1513-2113","authenticated-orcid":false,"given":"Cristina","family":"Tassorelli","sequence":"additional","affiliation":[{"name":"Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy"},{"name":"Headache Science and Neurorehabilitation Unit, IRCCS Mondino Foundation, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9415-4948","authenticated-orcid":false,"given":"Roberto","family":"De Icco","sequence":"additional","affiliation":[{"name":"Department of Brain and Behavioral Sciences, University of Pavia, Pavia 27100, Italy Headache Science and Neurorehabilitation Unit, IRCCS Mondino Foundation, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,12,21]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-023-01652-8"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/papr.12461"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-024-07493-w"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2023.5549"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-023-01676-0"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1177\/03331024241278911"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-024-00589-3"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000006641"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awz134"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2021.1912599"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-020-01132-3"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1177\/0333102410370873"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000001801"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/bph.14832"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-019-0789-6"},{"key":"e_1_3_4_17_2","article-title":"International Headache Society global practice recommendations for the acute pharmacological treatment of migraine","volume":"44","author":"Puledda F","year":"2024","unstructured":"Puledda F, Sacco S, Diener HC, et al. International Headache Society global practice recommendations for the acute pharmacological treatment of migraine. Cephalalgia 2024; 44(8): 3331024241252666.","journal-title":"Cephalalgia"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1177\/0333102421989232"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1177\/03331024231161745"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-020-01088-4"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-024-01904-1"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-024-01723-4"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1177\/03331024231151419"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1177\/03331024241258695"},{"key":"e_1_3_4_25_2","first-page":"1","article-title":"Functional Restoration with rEyvow (FREE): a US based cross sectional survey in patient taking lasmiditan","volume":"61","author":"Schwedt T","year":"2021","unstructured":"Schwedt T, Lombard L, Doty E, et al. Functional Restoration with rEyvow (FREE): a US based cross sectional survey in patient taking lasmiditan. Headache 2021; 61(Suppl 1): 1\u2013178.","journal-title":"Headache"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-023-01050-3"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1177\/0333102417738202"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1177\/0333102410379890"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(00)00305-5"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2006.00403.x"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1177\/0333102419828967"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1177\/0333102420941839"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-024-01935-8"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/head.14122"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1177\/0333102419859313"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1177\/0333102419864132"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2021.1903846"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1177\/0333102420920006"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1177\/0333102419889350"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-080107"}],"container-title":["Therapeutic Advances in Neurological Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17562864251381886","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/17562864251381886","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17562864251381886","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T17:37:54Z","timestamp":1769362674000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/17562864251381886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":39,"alternative-id":["10.1177\/17562864251381886"],"URL":"https:\/\/doi.org\/10.1177\/17562864251381886","relation":{},"ISSN":["1756-2864","1756-2864"],"issn-type":[{"value":"1756-2864","type":"print"},{"value":"1756-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]},"article-number":"17562864251381886"}}